# Thomas J. Lynch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thomas-j-lynch/

## Facts

| Field | Value |
| --- | --- |
| Citations | 56,140 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 84 |
| i10-index | 231 |
| Last Known Institution | Nationwide Children's Hospital |
| OpenAlex ID | https://openalex.org/A5003723404 |
| ORCID iD | https://orcid.org/0000-0001-8789-7567 |
| Works | 399 |

## Researcher papers

- [Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer](https://scholariq.org/papers/early-palliative-care-for-patients-with-metastatic-non-small-cell-lung-cancer/)
- [Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer](https://scholariq.org/papers/anaplastic-lymphoma-kinase-inhibition-in-non-small-cell-lung-cancer/)
- [Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors](https://scholariq.org/papers/genotypic-and-histological-evolution-of-lung-cancers-acquiring-resistance-to/)
- [Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>](https://scholariq.org/papers/clinical-features-and-outcome-of-patients-with-non-small-cell-lung-cancer-who/)
- [Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells](https://scholariq.org/papers/detection-of-mutations-in-i-egfr-i-in-circulating-lung-cancer-cells/)
- [First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EGFR</i>Mutations](https://scholariq.org/papers/first-line-gefitinib-in-patients-with-advanced-non-small-cell-lung-cancer/)
- [Longitudinal Perceptions of Prognosis and Goals of Therapy in Patients With Metastatic Non–Small-Cell Lung Cancer: Results of a Randomized Study of Early Palliative Care](https://scholariq.org/papers/longitudinal-perceptions-of-prognosis-and-goals-of-therapy-in-patients-with/)
- [Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib](https://scholariq.org/papers/exon-19-deletion-mutations-of-epidermal-growth-factor-receptor-are-associated/)
- [Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice](https://scholariq.org/papers/implementing-multiplexed-genotyping-of-non-small-cell-lung-cancers-into-routine/)
- [Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.](https://scholariq.org/papers/polymorphisms-in-the-dna-repair-genes-xrcc1-and-ercc2-smoking-and-lung-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Nationwide Children's Hospital](https://scholariq.org/institutions/nationwide-children-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.